Talking to ET Now, S Ramesh, CFO, Lupin , says there were problems associated with manufacturing in America itself but that those problems are behind the company now. Edited excerpts:
For More Details Visit-
via Things should normalise for pharma sector from FY20-21: S Ramesh, Lupin
No comments:
Post a Comment